[EXHIBIT 99.1.2]
[Letterhead of Xxxxxx-Xxxxxxx Company]
May 22, 1997
Pfizer Inc.
000 Xxxx 00xx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000-5755
Attention: President, U.S. Pharmaceutical Group
Re: Baseline Sales Adjustment
Dear Sirs:
Reference is hereby made to the Collaboration Agreement, effective as of
June 28, 1996 (the "Collaboration Agreement"), between Xxxxxx-Xxxxxxx
Company ("Xxxxxx-Xxxxxxx") and Pfizer Inc. ("Pfizer"). All capitalized
terms used and not otherwise defined herein shall have the meanings given
thereto under the Collaboration Agreement.
Xxxxxx-Xxxxxxx hereby notifies Pfizer that the Launch Date occurred on
January 28, 1997.
This represents a "stub period" of 63 days from January 28, 1997 through
March 31, 1997. In accordance with Section 3.06 of the Collaboration
Agreement, the adjusted Baseline Sales are as follows:
Agreement Year Adjusted Baseline Sales (in millions)
-------------- -------------------------------------
1 $263
2 $337
3 $457
4 $541
5 $588
6 $612
7 $651
8 $688
9 $763
10 $753
Please indicate your agreement with the foregoing by signing and returning
the enclosed copy of this letter.
Very truly yours,
XXXXXX-XXXXXXX COMPANY
By: /s/ Xxxxxxx X. Xxx Xxxxx
-------------------------
Xxxxxxx X. Xxx Xxxxx
Vice President, Corporate
Development & Licensing
RBVD:jsc
cc: Pfizer Inc.
Attn: Senior Vice President and General Counsel
(fax: 000-000-0000)
Agreed:
PFIZER INC.
By: /s/ Xxxxx X. Xxxxx
-----------------------------
Name: Xxxxx X. Xxxxx
Title: Vice President
